Satoru Yoshihiro

Urinary interleukin-2 may predict clinical outcome of intravesical bacillus Calmette-Gu�rin immunotherapy for carcinoma in situ of the bladder

Etsuya Watanabe, Hideyasu Matsuyama, Kenji Matsuda et al. · Cancer Immunology Immunotherapy · 2003 · 89 citations · Full text

Medicine, Immunology, Urology +15

Centrosome Hyperamplification Predicts Progression and Tumor Recurrence in Bladder Cancer

Yoshiaki Yamamoto, Hideyasu Matsuyama, Tomoko Furuya et al. · Clinical Cancer Research · 2004 · 74 citations · Full text

Medicine, Genetics, Oncology +17

Clinical significance of chromosome 8p, 10q, and 16q deletions in prostate cancer

Hideyasu Matsuyama, Yi Pan, Satoru Yoshihiro et al. · The Prostate · 2002 · 56 citations

Medicine, Molecular Genetics, Oncology +15

A single nucleotide polymorphism in the matrix metalloproteinase‐1 promoter is associated with conventional renal cell carcinoma

Hiroshi Hirata, Katsusuke Naito, Satoru Yoshihiro et al. · International Journal of Cancer · 2003 · 56 citations · Full text

Medicine, Genetics, Molecular Genetics +16

Contents Vol. 21, 2001

Tetsu Akimoto, Hideaki Takahashi, Yukio Miyata et al. · American Journal of Nephrology · 2001 · 54 citations · Full text

Natural Sciences, Chemistry, Documentation +1